Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerecor Inc (CERC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Free Research Reports on these Biotech Stocks -- Vericel, ZIOPHARM Oncology, Cerecor, and CASI Pharma

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on VCEL, ZIOP, CERC, and CASI which is a click away at http://www.wallstequities.com/registration....

ZIOP : 4.20 (-3.67%)
CASI : 3.79 (+1.07%)
VCEL : 6.25 (-5.66%)
CERC : 2.60 (-5.11%)
This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice

With First Investment Bank Analyst Report, Wall St Reveals they're Taking this Revenue-generating Cannabis Company Seriously

MARA : 3.59 (-13.91%)
SLTK : 1.6000 (-3.61%)
CERC : 2.60 (-5.11%)
Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals

Research Desk Line-up: AscendisPharmaPostEarnings Coverage

ASND : 47.60 (+2.19%)
CERC : 2.60 (-5.11%)
Cerecor Announces Leadership Changes

Appoints Randal O. Jones and Robert C. Moscato, Jr. to Board of Directors; Names Moscato as President and Chief Operating Officer

CERC : 2.60 (-5.11%)
Cerecor Inc. Reports Third Quarter 2017 Financial Results

Current cash and escrowed cash receivables in excess of $27 million

CERC : 2.60 (-5.11%)
Cerecor Inc. Reports Third Quarter 2017 Financial Results

Current cash and escrowed cash receivables in excess of $27 million

CERC : 2.60 (-5.11%)
Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement

BALTIMORE, MD--(Marketwired - October 18, 2017) - Cerecor, Inc. (NASDAQ: CERC), a biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders,...

CERC : 2.60 (-5.11%)
Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement

BALTIMORE, MD--(Marketwired - October 18, 2017) - Cerecor, Inc. (NASDAQ: CERC), a biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders,...

CERC : 2.60 (-5.11%)
Stock Performance Review on Biotech Industry -- Vertex Pharma, Axovant Sciences, Cerecor, and Ocular Therapeutix

If you want a Stock Review on VRTX, AXON, CERC, or OCUL then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Wednesday, the NASDAQ Composite ended...

VRTX : 155.71 (-1.41%)
AXON : 2.11 (+0.96%)
CERC : 2.60 (-5.11%)
OCUL : 5.30 (-5.36%)
Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.

BALTIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders,...

CERC : 2.60 (-5.11%)
Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.

BALTIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders,...

CERC : 2.60 (-5.11%)
Cerecor to present at the American Society for Clinical Psychopharmacology Conference

BALTIMORE, MD--(Marketwired - May 30, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological...

CERC : 2.60 (-5.11%)
Cerecor to present at the American Society for Clinical Psychopharmacology Conference

BALTIMORE, MD--(Marketwired - May 30, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological...

CERC : 2.60 (-5.11%)
Cerecor Inc. Reports First Quarter 2017 Financial Results

BALTIMORE, MD--(Marketwired - May 09, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological...

CERC : 2.60 (-5.11%)
Cerecor Inc. Reports First Quarter 2017 Financial Results

BALTIMORE, MD--(Marketwired - May 09, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological...

CERC : 2.60 (-5.11%)

Van Meerten Stock Picks

My 5 Favorite Mid Cap Stocks
This morning I wanted to find 5 Mid Cap stocks that had great returns over the past year and still seem to have some juice left.
KBH -1.63 , IPGP +2.02 , FSLR -2.19 , NVR -17.23 , SGMS +0.25
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.39%) are up +0.41% at a fresh record nearest-futures high as growth optimism fuels gains in global equity markets. Gains in technology stocks are leading the overall market higher as... Read More

Chart of the Day

Chart of the Day

Audentes Therapeutcs (BOLD) is rhe Barchart Chart of the Day.  The biomedical company has a Trend Spotter buy signal, a Weighted Alpha of 174.58+ and gained 111.74% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures bounced back from Friday’s bearish USDA reports to close Tuesday with gains of 2 cents in most nearby contracts. The weekly Export Inspections report indicated just 584,389 MT of corn was shipped during the week of Jan 11. That is ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.